1. Home
  2. PDYN vs TLSI Comparison

PDYN vs TLSI Comparison

Compare PDYN & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$6.64

Market Cap

291.5M

Sector

Industrials

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.88

Market Cap

267.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
TLSI
Founded
1983
2010
Country
United States
United States
Employees
N/A
110
Industry
Wholesale Distributors
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.5M
267.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDYN
TLSI
Price
$6.64
$3.88
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$8.00
$7.00
AVG Volume (30 Days)
3.2M
218.2K
Earning Date
03-05-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$199.22
$41.93
Revenue Next Year
$104.23
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$3.42
52 Week High
$12.79
$7.95

Technical Indicators

Market Signals
Indicator
PDYN
TLSI
Relative Strength Index (RSI) 46.51 30.16
Support Level $6.57 $3.79
Resistance Level $7.89 $5.51
Average True Range (ATR) 0.74 0.30
MACD -0.18 -0.07
Stochastic Oscillator 15.57 8.42

Price Performance

Historical Comparison
PDYN
TLSI

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: